The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Quantitative Nanostructure−Activity Relationship Modeling
Open accessAbstract
Evaluation of biological effects, both desired and undesired, caused by manufactured nanoparticles (MNPs) is of critical importance for nanotechnology. Experimental studies, especially toxicological, are time-consuming, costly, and often impractical, calling for the development of efficient computational approaches capable of predicting biological effects of MNPs. To this end, we have investigated the potential of cheminformatics methods such as quantitative structure-activity relationship (QSAR) modeling to establish statistically significant relationships between measured biological activity profiles of MNPs and their physical, chemical, and geometrical properties, either measured experimentally or computed from the structure of MNPs. To reflect the context of the study, we termed our approach quantitative nanostructure-activity relationship (QNAR) modeling. We have employed two representative sets of MNPs studied recently using in vitro cell-based assays: (i) 51 various MNPs with diverse metal cores (Proc. Natl. Acad. Sci. 2008, 105, 7387-7392) and (ii) 109 MNPs with similar core but diverse surface modifiers (Nat. Biotechnol. 2005, 23, 1418-1423). We have generated QNAR models using machine learning approaches such as support vector machine (SVM)-based classification and k nearest neighbors (kNN)-based regression; their external prediction power was shown to be as high as 73% for classification modeling and having an R(2) of 0.72 for regression modeling. Our results suggest that QNAR models can be employed for: (i) predicting biological activity profiles of novel nanomaterials, and (ii) prioritizing the design and manufacturing of nanomaterials toward better and safer products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Handbook of Molecular Descriptors
Todeschini, R., & Consonni, V. (2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613106 · Cited by 4,107
Golbraikh, A., & Tropsha, A. (2002) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(01)00123-1 · Cited by 3,735
Self-citationPULSKAMP, K., DIABATE, S., & KRUG, H. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2006.11.001 · Cited by 1,004
Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology
Oberdörster, G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02187.x · Cited by 943
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T., & Josephson, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1159 · Cited by 904
Self-citationFourches, D., Muratov, E., & Tropsha, A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100176x · Cited by 832
Self-citationDonaldson, K., Stone, V, Tran, C. L., Kreyling, W., & Borm, P. J. A. (2004) · Occupational and Environmental Medicine · doi:10.1136/oem.2004.013243 · Cited by 699
Nanoparticles: Their potential toxicity, waste and environmental management
Bystrzejewska-Piotrowska, G., Golimowski, J., & Urban, P. L. (2009) · Waste Management · doi:10.1016/j.wasman.2009.04.001 · Cited by 644
Nanoparticle‐induced platelet aggregation and vascular thrombosis
Radomski, A., Jurasz, P., Alonso‐Escolano, D., Drews, M., Morandi, M., Malinski, T., & Radomski, M. W. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706386 · Cited by 636
Cited by
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
Self-citationNanotechnology: A New Opportunity in Plant Sciences
Wang, P., Lombi, E., Zhao, F.-J., & Kopittke, P. M. (2016) · Trends in Plant Science · doi:10.1016/j.tplants.2016.04.005 · Cited by 1,062
Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913
Self-citationDeep learning for computational chemistry
Goh, G. B., Hodas, N. O., & Vishnu, A. (2017) · Journal of Computational Chemistry · doi:10.1002/jcc.24764 · Cited by 809
Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles
Walkey, C. D., Olsen, J. B., Song, F., Liu, R., Guo, H., Olsen, D. W. H., Cohen, Y., Emili, A., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn406018q · Cited by 815
Imaging macrophages with nanoparticles
Weissleder, R., Nahrendorf, M., & Pittet, M. J. (2014) · Nature Materials · doi:10.1038/nmat3780 · Cited by 809
Protein corona: a new approach for nanomedicine design
Nguyen, V. H., & Lee, B.-J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129300 · Cited by 638
In Vivo Biodistribution of Nanoparticles
Almeida, J. P. M., Chen, A. L., Foster, A., & Drezek, R. (2011) · Nanomedicine · doi:10.2217/nnm.11.79 · Cited by 583
Quantitative Structure–Property Relationship Modeling of Diverse Materials Properties
Le, T., Epa, V. C., Burden, F. R., & Winkler, D. A. (2012) · Chemical Reviews · doi:10.1021/cr200066h · Cited by 565
Metabolism of Nanomaterials in Vivo: Blood Circulation and Organ Clearance
Wang, B., He, X., Zhang, Z., Zhao, Y., & Feng, W. (2013) · Accounts of Chemical Research · doi:10.1021/ar2003336 · Cited by 531
Big data and artificial intelligence modeling for drug discovery
Zhu, H. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023324 · Cited by 455
Ivask, A., Juganson, K., Bondarenko, O., Mortimer, M., Aruoja, V., Kasemets, K., Blinova, I., Heinlaan, M., Slaveykova, V., & Kahru, A. (2014) · Nanotoxicology · doi:10.3109/17435390.2013.855831 · Cited by 332
Nabeshi, H., Yoshikawa, T., Matsuyama, K., Nakazato, Y., Tochigi, S., Kondoh, S., Hirai, T., Akase, T., Nagano, K., Abe, Y., et al. (2011) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-8-1 · Cited by 321
Singh, A. V., Ansari, M. H. D., Rosenkranz, D., Maharjan, R. S., Kriegel, F. L., Gandhi, K., Kanase, A., Singh, R., Laux, P., & Luch, A. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901862 · Cited by 310
Safety assessment of nanomaterials: Implications for nanomedicine
Nyström, A. M., & Fadeel, B. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.027 · Cited by 264
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Recent advances in dendrimer-based nanoplatform for cancer treatment: A review
Ambekar, R. S., Choudhary, M., & Kandasubramanian, B. (2020) · European Polymer Journal · doi:10.1016/j.eurpolymj.2020.109546 · Cited by 126
Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine
Moradi Kashkooli, F., Soltani, M., Souri, M., Meaney, C., & Kohandel, M. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101057 · Cited by 120
Khan, P. M., & Roy, K. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1542428 · Cited by 113
Fourches, D., Pu, D., & Tropsha, A. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711794728743 · Cited by 92
Self-citationEnhancing Clinical Translation of Cancer Using Nanoinformatics
Soltani, M., Moradi Kashkooli, F., Souri, M., Zare Harofte, S., Harati, T., Khadem, A., Haeri Pour, M., & Raahemifar, K. (2021) · Cancers · doi:10.3390/cancers13102481 · Cited by 82
Gajewicz, A. (2017) · Nanoscale · doi:10.1039/c7nr02211e · Cited by 71
Reproducibility, sharing and progress in nanomaterial databases
Tropsha, A., Mills, K. C., & Hickey, A. J. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.233 · Cited by 54
Self-citation
Metadata
- Authors
- Fourches, D., Pu, D., Tassa, C., Weissleder, R., Shaw, S. Y., Mumper, R. J., & Tropsha, A.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-09-21
- Volume
- 4
- Issue
- 10
- Pages
- 5703-5712
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2033192435
- Cited by
- 388
- References
- 40
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.